Skip to content

The Efficacy of Tai Chi Training for the Prophylaxis of Migraine in Chinese Women

A Pilot Randomized Controlled Trial to Test the Complementary Therapeutic Efficacy of Tai Chi for the Prophylaxis of Episodic Migraine in Chinese Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03015753
Enrollment
82
Registered
2017-01-10
Start date
2016-02-29
Completion date
2018-06-30
Last updated
2022-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine Disorder

Keywords

Migraine, Tai Chi, Prophylaxis, Randomized controlled trial

Brief summary

The proposed study aims to preliminarily test the effects of a 12-week Tai Chi training on the prophylaxis of episodic migraine in Chinese women, and to evaluate the feasibility, acceptability, compliance and maintenance of Tai Chi exercise among this population.

Detailed description

Migraine is a disabling neurological condition, characterized by attacks of headache and associated symptoms such as photophobia, nausea, and vomiting. In Hong Kong, the overall prevalence is around 12.5%. People with repeated migraine attacks are pain and personal suffering, have impaired social and personal life, and increased financial cost of medication. More nonpharmacologic prophylactic treatments are needed to reduce the high disease burden. As a body-mind exercise, Tai Chi's potential therapeutic efficacy on the prophylaxis of migraine has caught our attention. The investigators propose to conduct a two-arm individual level randomized controlled trial. Local women diagnosed with episodic migraine between 18-65 years will be randomly assigned to one of two groups: 1) a Tai Chi training (TC); or 2) a waiting list control group (control). The control group will receive a delayed Tai Chi training at the end of the trial. A total of 60 participants will be randomized and the intervention period will be 12 weeks with another 12-week follow-up. Number of attacks per month (frequency of attack), intensity and duration of headache, stress, sleep quality and quantity, fatigue, HRQoL, and body composition will be measured at baseline and at 12 weeks and 24 weeks. The primary outcomes are the difference in frequency of attack from baseline to the 12 weeks after randomization, and the proportion of patients with at least a 50% reduction of the number of attacks per month. The intervention effect will be estimated by calculating the differences of outcomes from baseline to the end of the trial between the intervention and control groups using intention-to-treat analysis.

Interventions

The 12-week Tai Chi training will be prescribed with three 1-hour instructor-led sessions and two 1-hour self-practice sessions per week. A modified 32-short form Yang-style Tai Chi Chuan will be adopted. The instructor-led sessions will be operated by qualified Tai Chi masters. The training activity will be delivered in group. The group size is 15 to 18 persons.

At the end of the trial, participants in this arm will be offered Tai Chi training similar as Tai Chi training (TC) group.

Sponsors

The Hong Kong Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Female, aged 18-65 years; * Have a clinical diagnosis of episodic migraine according to ICHD-II criteria at least 2 months prior to enrollment; * At least one of the following migraine characteristics is met: nausea, vomiting, photophobia, or phonophobia; * Able to undertake designated level of Tai Chi exercise; * Live in Hong Kong, can read and speak Cantonese or Putonghua.

Exclusion criteria

* Severe migraine attacks with disabilities that cannot perform moderate intensity physical activity; * Secondary headache and other neurological disease; * More than 5 days of non-migrainous headache per month; * Experience with Tai Chi practice after diagnosis of migraine; * Regular performance of Tai Chi or other body-mind exercises (yoga, biofeedback, medication, etc.); * Undergoing other alternative therapeutic treatments during recruitment period, or received other alternative therapeutic treatments in the past 12 weeks; * Pregnancy, lactation period, or currently using contraceptives; * Use of pharmacological prophylactic treatment for migraine in the past 12 weeks; * Drug abuse, take antipsychotic or antidepressant drugs, or take analgesics for other chronic pain more than 3 days a month in the past 12 weeks; * Epilepsy, or have a psychiatric disease.

Design outcomes

Primary

MeasureTime frameDescription
The difference in frequency of migraine attacks (the number of attacks per month)From baseline to 12 weeks
The proportion of respondersFrom baseline to 12 weeksDefined as the proportion of patients with at least a 50% reduction of the number of attacks per month

Secondary

MeasureTime frameDescription
Stress statusFrom the baseline to 12 weeks and 24 weeksThe Perceived Stress Scale (PSS) will be used to measure the stress level.
Sleep qualityFrom the baseline to 12 weeks and 24 weeksThe Chinese version of the Pittsburgh Sleep Quality Index (PSQI) will be used to measure the sleep quality.
Sleep quantityFrom the baseline to 12 weeks and 24 weeksA 7-day daily sleep log will be used to measure the sleep quantity.
Fatigue levelFrom the baseline to 12 weeks and 24 weeksThe Numeric Rating Scale-fatigue (NRS-fatigue) will be used to measure fatigue level.
HRQoLFrom the baseline to 12 weeks and 24 weeksHRQoL will be measured by using the Chinese version of the SF-36.
WeightFrom the baseline to 12 weeks and 24 weeksWeight in kilograms
HeightFrom the baseline to 12 weeks and 24 weeksHeight in meters
Waist circumferenceFrom the baseline to 12 weeks and 24 weeksWaist in cm
Duration of headache attackFrom the baseline to 12 weeks and 24 weeks
Percent body fatFrom the baseline to 12 weeks and 24 weeks
Session attendance rateFrom baseline to 12 weeksNumber of participants who truly attend the Tai Chi training session divided by the total number of participants in that training session
The number of weeks the participants in intervention group practice Tai Chi at least one time per week in the 12-week follow up period12 weeks after Tai Chi trainingThis is to measure the maintenance of Tai Chi practice
The percentage of the participants in the intervention group who keep Tai Chi exercise for 1 time per week and last 6 weeks in the 12-week follow up period12 weeks after Tai Chi trainingThis is to measure the maintenance of Tai Chi practice
Participation rateAt baseline assessment (4 weeks)This outcome is measured by the eligible participants at baseline assessment divided by the subjects who register the study
Dropout rateFrom the baseline to 12 weeks and 24 weeksNumber of participants successfully complete the 12-week Tai Chi training and 12-week follow up divided by the number of participants at baseline
Adverse eventsDuring intervention period (12 weeks)
Hip circumferenceFrom baseline to 12 weeks and 24 weeksHip circumference in cm
Intensity of headacheFrom the baseline to 12 weeks and 24 weeksIntensity of headache will be measured by a Visual Analogue Scale.

Countries

Hong Kong

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026